Prevalence of anti-citrullinated protein antibodies (ACPA) in patients with diffuse large B-cell lymphoma (DLBCL): a case-control study.

Prevalence of anti-citrullinated protein antibodies (ACPA) in patients with diffuse large B-cell lymphoma (DLBCL): a case-control study.

BACKGROUND: Antibodies against citrullinated proteins (ACPA) have been recognised as the most specific serum marker for rheumatoid arthritis. However, serum autoantibodies such as anti-nuclear antibodies have also been detected in the sera of different lymphatic malignancies without accompanying rhe...

Full description

Bibliographic Details
Main Authors:	Gunter Assmann, Klara Shihadeh, Viola Poeschel, Niels Murawski, Jutta Conigliarou, Mei Fang Ong, Michael Pfreundschuh
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3917867?pdf=render

Similar Items

HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritis.
by: Nathalie Balandraud, et al.
Published: (2013-01-01)

Antibodies to Citrullinated Proteins (ACPA) Associate with Markers of Osteoclast Activation and Bone Destruction in the Bone Marrow of Patients with Rheumatoid Arthritis
by: Weronika Kurowska, et al.
Published: (2021-04-01)

Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
by: Wenqi Zhang, et al.
Published: (2021-01-01)

Shared epitope alleles remain a risk factor for anti-citrullinated proteins antibody (ACPA)--positive rheumatoid arthritis in three Asian ethnic groups.
by: Too Chun-Lai, et al.
Published: (2011-01-01)

The regulatory mechanism of cell death by rigosertib in diffuse large B-cell lymphoma (DLBCL)
by: Yi-HanDai, et al.
Published: (2015)

Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
by: Pengcheng Feng, et al.
Published: (2021-02-01)

Interleukin 10 gene promoter polymorphism and risk of diffuse large B cell lymphoma (DLBCL)
by: Roba M. Talaat, et al.
Published: (2014-01-01)

Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
by: Gleeson Michelle, et al.
Published: (2010-11-01)

The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical
by: Debbie M. Boeters, et al.
Published: (2017-05-01)

Adalimumab-Induced Rhupus Syndrome in a Female Patient Affected with Anti-Citrullinated Protein Antibody (ACPA)-Positive Rheumatoid Arthritis (RA): A Case Report and Review of Literature
by: Ciro Manzo, et al.
Published: (2021-07-01)

Analysis of host T-cell response in diffuse large B-cell lymphoma (DLBCL) and correlation with clinicopathological features
by: ChenChang, et al.
Published: (2015)

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
by: Lander, Eric Steven
Published: (2012)

Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab
by: Carrasquillo J, et al.
Published: (2009-06-01)

Do We Have the Right Prognostic Index for Diffuse Large B Cell Lymphoma (DLBCL) in the Era of Rituximab?
by: WM Tai MBBS(S'pore), MRCP(UK), et al.
Published: (2011-03-01)

The fear of lymphadenopathy: A cautionary case of sarcoidosis masquerading as recurrent diffuse large b-cell lymphoma (DLBCL)
by: Peter D. Whooley, et al.
Published: (2018-01-01)

Follicular lymphoma transforming to DLBCL and reverting back to follicular lymphoma at relapse—a case report
by: M. C. Suresh Babu, et al.
Published: (2020-05-01)

Elucidation of the Mechanisms of Resistance and Sensitivity to Histone Deacetylase Inhibitor, PXD101, in Diffuse Large B-Cell Lymphoma (DLBCL)
by: Tula Sanchez, Ana A.
Published: (2013)

The Role of Galectin-9 in Germinal Centre B-cell-like Diffuse Large B Cell Lymphoma (GCB-DLBCL)
by: Yen-Fei Wu, et al.
Published: (2016)

Les Échos de l'ACPAS
Published: (2009)

Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020–2025
by: Arnason, J.A, et al.
Published: (2022)

Clinical outcomes of people living with human immunodeficiency virus (HIV) with diffuse large B-cell lymphoma (DLBCL) in Shanghai, China
by: Jian-Jun Sun, et al.
Published: (2020-12-01)

Evaluation of the Proliferative Activity of Diffuse Large B-Cell Lymphoma (DLBCL) in Dogs with Respect to Patient Eligibility for Anthracycline-Based Chemotherapy
by: Paweł Klimiuk, et al.
Published: (2021-04-01)

Prediction of treatment response by anticitrullinated protein antibodies (ACPA) levels among patients with rheumatoid arthritis
by: Hernández Raquel, et al.
Published: (2012-11-01)

DLBCL Coast to Coast
by: Melania Tesio
Published: (2018-02-01)

ACPAs Are Much More Than Diagnostic Autoantibodies
by: Abdulla Watad, et al.
Published: (2016-10-01)

The Infectious Basis of ACPA-Positive Rheumatoid Arthritis
by: Lazaros I. Sakkas, et al.
Published: (2017-09-01)

50% versus 70%: is there a difference between these BCL2 cut-offs in immunohistochemistry for diffuse large B-cell lymphomas (DLBCL)?
by: Cristiano Claudino Oliveira, et al.
Published: (2020-09-01)

Evaluation of BCL6 and MUM1 Expression in Patients with Diffuse Large B Cell Lymphoma (DLBCL) and Their Correlation with Staging and Prognosis of the Disease
by: Hossein Rahimi, et al.
Published: (2015-01-01)

A multi-institutional analysis of diffuse large B-cell lymphoma (DLBCL) treated with consolidative radiotherapy and the impact of cell-of-origin on outcomes
by: Rajasooriyar Chrishanthi, et al.
Published: (2019-10-01)

Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients
by: Yuya Fujita, et al.
Published: (2020-04-01)

High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis
by: David Gomez-Cabrero, et al.
Published: (2016-11-01)

ROR1 Is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells
by: Amineh Ghaderi, et al.
Published: (2020-06-01)

Author Correction: Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL
by: Kavita Bhalla, et al.
Published: (2018-05-01)

Measuring ACPA in the general population or primary care: is it useful?
by: Axel Finckh, et al.
Published: (2020-05-01)

Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
by: E N Aleksandrova, et al.
Published: (2004-12-01)

Epitope Specificity of Anti-Citrullinated Protein Antibodies
by: Nicole H. Trier, et al.
Published: (2017-03-01)

Antibodies to citrullinated proteins in the pathogenesis of rheumatoid arthritis
by: Kinloch, Andrew James
Published: (2008)

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
by: Sara Harrysson, et al.
Published: (2021-01-01)

Expression of N6-methyladenosine (m6A) regulators correlates with immune microenvironment characteristics and predicts prognosis in diffuse large cell lymphoma (DLBCL)
by: Zucheng Xie, et al.
Published: (2021-01-01)

DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set
by: Damir Vrabac, et al.
Published: (2021-05-01)